Last 12 months
Inside the activity.
9 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 1 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2025 Filed May 20, 2025 21:08 UTC |
POLAN MARY LAKE PH DDirector
|
GrantCommon Stock | 128 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000073 · wk-form4_1747775295.xml · nonDerivative · entry 2 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,711 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:08 UTC |
POLAN MARY LAKE PH DDirector
|
GrantCommon Stock | 427 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000073 · wk-form4_1747775295.xml · nonDerivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,583 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:26 UTC |
RHOADS ANN DDirector
|
Exercise / conversionRestricted Stock Units (Premium ) · Derivative | 128 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000077 · wk-form4_1747776359.xml · derivative · entry 4 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 128 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:26 UTC |
RHOADS ANN DDirector
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 427 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000077 · wk-form4_1747776359.xml · derivative · entry 3 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 427 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:26 UTC |
RHOADS ANN DDirector
|
GrantCommon Stock | 128 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000077 · wk-form4_1747776359.xml · nonDerivative · entry 2 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,687 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:26 UTC |
RHOADS ANN DDirector
|
GrantCommon Stock | 427 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000077 · wk-form4_1747776359.xml · nonDerivative · entry 1 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,559 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:25 UTC |
Michael Edward L.Director
|
Exercise / conversionRestricted Stock Units (Premium ) · Derivative | 166 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000076 · wk-form4_1747776295.xml · derivative · entry 4 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 166 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:25 UTC |
Michael Edward L.Director
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 555 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000076 · wk-form4_1747776295.xml · derivative · entry 3 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 555 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:25 UTC |
Michael Edward L.Director
|
GrantCommon Stock | 166 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000076 · wk-form4_1747776295.xml · nonDerivative · entry 2 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,423 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 18, 2025 Filed May 20, 2025 21:25 UTC |
Michael Edward L.Director
|
GrantCommon Stock | 555 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000076 · wk-form4_1747776295.xml · nonDerivative · entry 1 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,257 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:18 UTC |
Blaser Brian J.President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 20,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000059 · wk-form4_1747685890.xml · derivative · entry 4 Blaser Brian J. · CIK 0001492289 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,518 Underlying: Common Stock · 20,759 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 20,759 shares vested on May 15, 2025; 20,759 shares will vest on May 15, 2026 and 20,759 shares will vest on May 15, 2027. F4 · derivative.expiration_date: 20,759 shares vested on May 15, 2025; 20,759 shares will vest on May 15, 2026 and 20,759 shares will vest on May 15, 2027. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:18 UTC |
Blaser Brian J.President and CEO
|
Tax withholdingCommon Stock | 9,308 | $33.03 | $307,443.24 |
DisclosureSEC source: 0001906324-25-000059 · wk-form4_1747685890.xml · nonDerivative · entry 2 Blaser Brian J. · CIK 0001492289 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,451 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:18 UTC |
Blaser Brian J.President and CEO
|
GrantCommon Stock | 20,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000059 · wk-form4_1747685890.xml · nonDerivative · entry 1 Blaser Brian J. · CIK 0001492289 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,759 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| April 26, 2025 Filed Apr 29, 2025 20:09 UTC |
McLellan Philip D.Chief Operations Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000052 · wk-form4_1745957339.xml · derivative · entry 3 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,946 Underlying: Common Stock · 1,945 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,945 shares vested on April 26, 2024 and 1,945 shares vested on April 26, 2025; 1,946 shares will vest on April 26, 2026. F4 · derivative.expiration_date: 1,945 shares vested on April 26, 2024 and 1,945 shares vested on April 26, 2025; 1,946 shares will vest on April 26, 2026. Read SEC document |
| April 26, 2025 Filed Apr 29, 2025 20:09 UTC |
McLellan Philip D.Chief Operations Officer
|
Tax withholdingCommon Stock | 696 | $28.09 | $19,550.64 |
DisclosureSEC source: 0001906324-25-000052 · wk-form4_1745957339.xml · nonDerivative · entry 2 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,237 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| April 26, 2025 Filed Apr 29, 2025 20:09 UTC |
McLellan Philip D.Chief Operations Officer
|
GrantCommon Stock | 1,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000052 · wk-form4_1745957339.xml · nonDerivative · entry 1 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,933 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 3. Read SEC document |
| April 22, 2025 Filed Apr 24, 2025 20:03 UTC |
McLellan Philip D.Chief Operations Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000050 · wk-form4_1745525017.xml · derivative · entry 3 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,476 Underlying: Common Stock · 3,237 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,237 shares vested on April 22, 2025; 6,476 shares will vest in equal installments on April 22, 2026 and April 22, 2027. F4 · derivative.expiration_date: 3,237 shares vested on April 22, 2025; 6,476 shares will vest in equal installments on April 22, 2026 and April 22, 2027. Read SEC document |
| April 22, 2025 Filed Apr 24, 2025 20:03 UTC |
McLellan Philip D.Chief Operations Officer
|
Tax withholdingCommon Stock | 1,159 | $24.46 | $28,349.14 |
DisclosureSEC source: 0001906324-25-000050 · wk-form4_1745525017.xml · nonDerivative · entry 2 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,988 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| April 22, 2025 Filed Apr 24, 2025 20:03 UTC |
McLellan Philip D.Chief Operations Officer
|
GrantCommon Stock | 3,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000050 · wk-form4_1745525017.xml · nonDerivative · entry 1 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,147 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| April 18, 2025 Filed Apr 22, 2025 16:03 UTC |
Hodges Michelle AChief Legal Officer
|
GrantRestricted Stock Units (Premium ) · Derivative | 3,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000048 · wk-form4_1745352212.xml · derivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,910 Underlying: Common Stock · 3,910 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units will vest on April 18, 2026. F2 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units will vest on April 18, 2026. Read SEC document |
| April 18, 2025 Filed Apr 22, 2025 16:03 UTC |
Hodges Michelle AChief Legal Officer
|
GrantRestricted Stock Units (Converted) · Derivative | 13,036 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000048 · wk-form4_1745352212.xml · derivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,036 Underlying: Common Stock · 13,036 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F3 · derivative.exercise_date: The restricted stock units vested on April 18, 2025. F2 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F3 · derivative.expiration_date: The restricted stock units vested on April 18, 2025. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 16:18 UTC |
Busky Joseph M.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000041 · wk-form4_1743538698.xml · derivative · entry 4 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,925 Underlying: Common Stock · 4,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 4,925 shares vested on March 28, 2025; the remaining 4,925 shares will vest on March 28, 2026. F4 · derivative.expiration_date: 4,925 shares vested on March 28, 2025; the remaining 4,925 shares will vest on March 28, 2026. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 16:18 UTC |
Busky Joseph M.Chief Financial Officer
|
Tax withholdingCommon Stock | 1,602 | $34.89 | $55,893.78 |
DisclosureSEC source: 0001906324-25-000041 · wk-form4_1743538698.xml · nonDerivative · entry 2 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,017 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 16:18 UTC |
Busky Joseph M.Chief Financial Officer
|
GrantCommon Stock | 4,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000041 · wk-form4_1743538698.xml · nonDerivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,619 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 16:17 UTC |
Hodges Michelle AChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000040 · wk-form4_1743538615.xml · derivative · entry 3 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,463 Underlying: Common Stock · 2,463 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 2,463 shares vested on March 28, 2025; the remaining 2,463 shares will vest on March 28, 2026. F4 · derivative.expiration_date: 2,463 shares vested on March 28, 2025; the remaining 2,463 shares will vest on March 28, 2026. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 16:17 UTC |
Hodges Michelle AChief Legal Officer
|
Tax withholdingCommon Stock | 882 | $34.89 | $30,772.98 |
DisclosureSEC source: 0001906324-25-000040 · wk-form4_1743538615.xml · nonDerivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,163 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 16:17 UTC |
Hodges Michelle AChief Legal Officer
|
GrantCommon Stock | 2,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000040 · wk-form4_1743538615.xml · nonDerivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,045 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 16:17 UTC |
Busky Joseph M.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000029 · wk-form4_1739308660.xml · derivative · entry 4 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,937 Underlying: Common Stock · 5,968 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 5, 968 shares vested on February 8, 2025; 5,968 shares will vest on February 8, 2026; and 5,969 shares will vest on February 8, 2027. F4 · derivative.expiration_date: 5, 968 shares vested on February 8, 2025; 5,968 shares will vest on February 8, 2026; and 5,969 shares will vest on February 8, 2027. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 16:17 UTC |
Busky Joseph M.Chief Financial Officer
|
Tax withholdingCommon Stock | 2,058 | $42.89 | $88,267.62 |
DisclosureSEC source: 0001906324-25-000029 · wk-form4_1739308660.xml · nonDerivative · entry 2 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,694 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 16:17 UTC |
Busky Joseph M.Chief Financial Officer
|
GrantCommon Stock | 5,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000029 · wk-form4_1739308660.xml · nonDerivative · entry 1 Busky Joseph M. · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,752 F1 · shares: Reflects release of restricted units that were previously reported on a Form 4. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 16:15 UTC |
Hodges Michelle AChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000027 · wk-form4_1739308537.xml · derivative · entry 3 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,396 Underlying: Common Stock · 3,197 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,197 shares vested on February 8, 2025; the remaining 6,396 shares will vest in equal installments on February 8, 2026 and February 8, 2027. F4 · derivative.expiration_date: 3,197 shares vested on February 8, 2025; the remaining 6,396 shares will vest in equal installments on February 8, 2026 and February 8, 2027. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 16:15 UTC |
Hodges Michelle AChief Legal Officer
|
Tax withholdingCommon Stock | 1,144 | $42.89 | $49,066.16 |
DisclosureSEC source: 0001906324-25-000027 · wk-form4_1739308537.xml · nonDerivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,582 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 16:15 UTC |
Hodges Michelle AChief Legal Officer
|
GrantCommon Stock | 3,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000027 · wk-form4_1739308537.xml · nonDerivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,726 F1 · shares: Reflects release of restricted units that were previously reported on a Form 4. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 21:15 UTC |
McLellan Philip D.Chief Operations Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 338 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000018 · wk-form4_1738703693.xml · derivative · entry 9 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 338 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F6 · derivative.exercise_date: 338 shares vested on February 1, 2025. F6 · derivative.expiration_date: 338 shares vested on February 1, 2025. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 21:15 UTC |
McLellan Philip D.Chief Operations Officer
|
Tax withholdingCommon Stock | 139 | $43.46 | $6,040.94 |
DisclosureSEC source: 0001906324-25-000018 · wk-form4_1738703693.xml · nonDerivative · entry 6 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,910 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 21:15 UTC |
McLellan Philip D.Chief Operations Officer
|
GrantCommon Stock | 338 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000018 · wk-form4_1738703693.xml · nonDerivative · entry 5 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,049 F1 · shares: Reflects release of restricted units that were previously reported on a Form 4. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 16:17 UTC |
Hodges Michelle AChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 474 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000020 · wk-form4_1738703818.xml · derivative · entry 9 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 474 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F7 · derivative.exercise_date: 474 shares vested on January 31, 2025. F7 · derivative.expiration_date: 474 shares vested on January 31, 2025. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 16:17 UTC |
Hodges Michelle AChief Legal Officer
|
Tax withholdingCommon Stock | 169 | $43.46 | $7,344.74 |
DisclosureSEC source: 0001906324-25-000020 · wk-form4_1738703818.xml · nonDerivative · entry 6 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,529 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 16:17 UTC |
Hodges Michelle AChief Legal Officer
|
GrantCommon Stock | 474 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000020 · wk-form4_1738703818.xml · nonDerivative · entry 5 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,698 F1 · shares: Reflects release of restricted units that were previously reported on a Form 4. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:15 UTC |
McLellan Philip D.Chief Operations Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 846 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000018 · wk-form4_1738703693.xml · derivative · entry 8 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 847 Underlying: Common Stock · 846 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 846 shares vested on January 31, 2025; the remaining 847 shares will vest on January 31, 2026. F5 · derivative.expiration_date: 846 shares vested on January 31, 2025; the remaining 847 shares will vest on January 31, 2026. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:15 UTC |
McLellan Philip D.Chief Operations Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000018 · wk-form4_1738703693.xml · derivative · entry 7 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,127 Underlying: Common Stock · 1,127 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,127 shares vested on January 31, 2025; the remaining 1,127 shares will vest on January 31, 2026. F4 · derivative.expiration_date: 1,127 shares vested on January 31, 2025; the remaining 1,127 shares will vest on January 31, 2026. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:15 UTC |
McLellan Philip D.Chief Operations Officer
|
Tax withholdingCommon Stock | 348 | $43.46 | $15,124.08 |
DisclosureSEC source: 0001906324-25-000018 · wk-form4_1738703693.xml · nonDerivative · entry 4 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,711 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:15 UTC |
McLellan Philip D.Chief Operations Officer
|
GrantCommon Stock | 846 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000018 · wk-form4_1738703693.xml · nonDerivative · entry 3 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,059 F1 · shares: Reflects release of restricted units that were previously reported on a Form 4. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:15 UTC |
McLellan Philip D.Chief Operations Officer
|
Tax withholdingCommon Stock | 463 | $43.46 | $20,121.98 |
DisclosureSEC source: 0001906324-25-000018 · wk-form4_1738703693.xml · nonDerivative · entry 2 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,213 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:15 UTC |
McLellan Philip D.Chief Operations Officer
|
GrantCommon Stock | 1,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000018 · wk-form4_1738703693.xml · nonDerivative · entry 1 McLellan Philip D. · CIK 0002045799 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,676 F1 · shares: Reflects release of restricted units that were previously reported on a Form 4. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:17 UTC |
Hodges Michelle AChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000020 · wk-form4_1738703818.xml · derivative · entry 8 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,814 Underlying: Common Stock · 1,814 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F6 · derivative.exercise_date: 1,814 shares vested on January 31, 2025; the remaining 1,814 shares will vest on January 31, 2026. F6 · derivative.expiration_date: 1,814 shares vested on January 31, 2025; the remaining 1,814 shares will vest on January 31, 2026. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:17 UTC |
Hodges Michelle AChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000020 · wk-form4_1738703818.xml · derivative · entry 7 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,610 Underlying: Common Stock · 1,610 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 1,610 shares vested on January 31, 2025; the remaining 1,610 shares will vest on January 31, 2026. F5 · derivative.expiration_date: 1,610 shares vested on January 31, 2025; the remaining 1,610 shares will vest on January 31, 2026. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:17 UTC |
Hodges Michelle AChief Legal Officer
|
Tax withholdingCommon Stock | 717 | $43.46 | $31,160.82 |
DisclosureSEC source: 0001906324-25-000020 · wk-form4_1738703818.xml · nonDerivative · entry 4 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,224 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:17 UTC |
Hodges Michelle AChief Legal Officer
|
GrantCommon Stock | 1,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000020 · wk-form4_1738703818.xml · nonDerivative · entry 3 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,941 F1 · shares: Reflects release of restricted units that were previously reported on a Form 4. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:17 UTC |
Hodges Michelle AChief Legal Officer
|
Tax withholdingCommon Stock | 662 | $43.46 | $28,770.52 |
DisclosureSEC source: 0001906324-25-000020 · wk-form4_1738703818.xml · nonDerivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,127 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.